NCT00456508 · Interventional trial
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Overall registry status Completed
Phase 3
Conditions Hereditary Angioedema (HAE)
Delaware Valley sites
- Asthma Allergy and Pulmonary Associates · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory